Literature DB >> 6222113

Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.

R I Fisher, F Bostick-Bruton, D N Sauder, G Scala, V Diehl.   

Abstract

Neoplastic cells obtained from the pleural effusion of a patient with Hodgkin's disease have been maintained in culture since 1978. These tumor cells have been shown to have the cytologic features, cytochemical staining, and cell surface markers of Reed-Sternberg cells. In this study we demonstrate that the cell line termed L428 is a potent stimulator of the primary human mixed lymphocyte reaction. Significant proliferation occurred when mononuclear leukocytes obtained from normal donors were stimulated with radiated L428 cells at responder:stimulator ratios varying from 200:1 to 20:1. Proliferative responses occurred between days 3 and 6 of the cultures with maximal proliferation on day 5. Under optimal culture conditions, mean net proliferative response of 14 normal donors was 51,000 +/- 10,600 dpm. The mixed lymphocyte response was totally blocked by concentrations of monoclonal anti-Ia antibody that had no effect on concanavalin A-induced proliferation. However, the mixed lymphocyte response was not blocked by an anti-K562 cell monoclonal antibody of the same immunoglobulin subclass that binds to the L428 cells. Antigen processing by responder monocytes or Ia-positive cells was not required for the MLC. When responder T cells from two normals were depleted of Ia-bearing cells and monocytes, the mixed lymphocyte reaction between the two normals was eliminated, yet the stimulation of each normal by the L428 cells was not reduced. The cells that proliferated in response to stimulation by the L428 cells were T cells, primarily of the helper subset. No IL 1 activity could be detected in concentrated supernatants of L428 cultures after stimulation of L428 cells by mitogens, phorbol esters, or muramyl dipeptide, or in the MLC. All of these cultures contain fetal calf serum. However, the L428 cells are capable of producing IL 1, because IL 1 was detected when the L428 cells were stimulated with LPS in the absence of fetal calf serum. These neoplastic cells, obtained from Hodgkin's disease, have many similarities to the murine as well as human dendritic cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222113

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Hodgkin's cells express a novel pattern of adhesion molecules.

Authors:  P A Ellis; D N Hart; B M Colls; J C Nimmo; J E MacDonald; H B Angus
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.

Authors:  S M Hsu; S S Xie; P L Hsu
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?

Authors:  G S Pinkus; J L Pinkus; E Langhoff; F Matsumura; S Yamashiro; G Mosialos; J W Said
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue.

Authors:  J Gerdes; R Schwarting; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

Review 6.  Hodgkin's disease: the Sternberg-Reed cell.

Authors:  P Bucsky
Journal:  Blut       Date:  1987-11

7.  Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cells.

Authors:  Benjamin Rengstl; Frederike Schmid; Christian Weiser; Claudia Döring; Tim Heinrich; Kathrin Warner; Petra S A Becker; Robin Wistinghausen; Sima Kameh-Var; Eva Werling; Arne Billmeier; Christian Seidl; Sylvia Hartmann; Hinrich Abken; Ralf Küppers; Martin-Leo Hansmann; Sebastian Newrzela
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

8.  Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

Authors:  C Kretschmer; D B Jones; K Morrison; C Schlüter; W Feist; A J Ulmer; J Arnoldi; J Matthes; T Diamantstein; H D Flad
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

9.  Interdigitating cell sarcoma (ICS). Evidence of interdigitating cell origin, immunocytochemical studies with monoclonal anti-ICS antibodies.

Authors:  S Nakamura; T Suchi; R Suzuki; N Takagi; K Kitoh; H Osada; R Ueda; T Takahashi; H Hiai; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

10.  Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.

Authors:  J L McKenzie; W Egner; V L Calder; D N Hart
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.